初级评估疗效指标是肾小球过滤率的变化，观察在18个月和36个月（3年）的肾小球滤过率（GFR）变化。
The primary outcome measure was progression of nephropathy, which was assessed by change in glomerular filtration rate (GFR) at 18 and 36 months.
胱抑素c是一种小分子量分泌性蛋白质，一直是评估肾小球滤过率的标示物。
Cystatin c, a small molecular weight secreted protein, is a marker for evaluating glomerular filtration.
胱抑素c是一种小分子量分泌性蛋白质，一直是评估肾小球滤过率的标示物。
Cystatin c, a small molecular weight secreted protein, is a marker for evaluating glomerular filtration.
应用推荐